Evidence map›Paper›PMID 10362356›Full record

ArticleOncogene1999

Contribution of Src and Ras pathways in FGF-2 induced endothelial cell differentiation.

P Klint, S Kanda, Y Kloog, L Claesson-Welsh

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Oncogene, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed.

  1. Article
  2. Key Role of Astrocytes in Postnatal Brain and Retinal Angiogenesis.International journal of molecular sciences · 2022
    Review
  3. Review
  4. Genetic deletion of endothelial microRNA-15a/16-1 promotes cerebral angiogenesis and neurological recovery in ischemic stroke through Src signaling pathway.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2021
    Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Molecular interactions in juvenile nasopharyngeal angiofibroma: preliminary signature and relevant review.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2019
    Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Role of neurotrophic factor alterations in the neurodegenerative process in HIV associated neurocognitive disorders.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2014
    Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

P KlintDepartment of Medical Biochemistry and Microbiology, BMC, Uppsala, Sweden.
S Kanda
Y Kloog
L Claesson-Welsh

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We have examined fibroblast growth factor (FGF) receptor-1 mediated signal transduction in differentiation of endothelial cells (EC). The activated FGFR-1 couples to Ras through two adaptor proteins, FRS2 and Shc. In FGF-2 treated proliferating EC, FRS2 as well as Shc are tyrosine phosphorylated and interact with Grb2. In contrast, in FGF-2 treated differentiating cells, Shc, but not FRS2, is engaged in Grb2-interactions. Sustained MAP kinase activity has previously been implicated in differentiation. In FGF stimulated proliferating and differentiating endothelial cells, the MAP kinase Erk2 is activated in a sustained manner. Inhibition of MEK and MAP kinase activity by PD98059 treatment of cells, still allows EC tube formation. The FGFR-1 mediates activation of protein kinase C (PKC) through direct binding and activation of phospholipase C-gamma (PLC-gamma), and has also been shown to activate the cytoplasmic tyrosine kinase Src. Treatment of the cells with the PKC inhibitor bisindolylmaleimide does not prevent tube formation. In contrast, Src kinase activity is a prerequisite for EC differentiation, since treatment of the cells with PP1, a Src family specific inhibitor, abrogates tube formation. In differentiating EC, FGF-2 induces complex formation between Src and focal adhesion kinase (FAK). These data indicate that the Ras pathway is initiated via Shc or FRS2, dependent on the cellular program. Blocking the function of Src family kinases, attenuates differentiation.

Indexed as

Adaptor Proteins, Signal TransducingGenes, rassrc Homology DomainsAnimalsBecaplerminCalcium-Calmodulin-Dependent Protein KinasesCell Adhesion MoleculesCell DifferentiationCell DivisionCell LineEndothelium, VascularEnzyme InhibitorsFibroblast Growth Factor 2FlavonoidsFocal Adhesion Kinase 1Focal Adhesion Protein-Tyrosine Kinases2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-oneAdaptor Proteins, Signal TransducingBecaplerminbisindolylmaleimide ICalcium-Calmodulin-Dependent Protein KinasesCell Adhesion MoleculesEnzyme InhibitorsFgfr1 protein, mouseFibroblast Growth Factor 2FlavonoidsFocal Adhesion Kinase 1Focal Adhesion Protein-Tyrosine KinasesFRS2 protein, humanGRB2 Adaptor ProteinGrb2 protein, mouseIndolesIsoenzymesMaleimidesMembrane ProteinsPhospholipase C gammaPhosphoproteinsPlatelet-Derived Growth FactorProtein Kinase CProteinsProtein-Tyrosine KinasesProto-Oncogene Proteins c-sisPtk2 protein, mouseras ProteinsReceptor, Fibroblast Growth Factor, Type 1Receptor Protein-Tyrosine KinasesReceptors, Fibroblast Growth FactorRecombinant ProteinsType C Phospholipases

Identifiers

PMID10362356

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.